 | • レポートコード：GIR-2104Z11873 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、レミケードバイオシミラーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。レミケードバイオシミラーの種類別市場規模（100mg/10ml、500mg/50ml）、用途別市場規模（血液疾患、腫瘍疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・レミケードバイオシミラーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Synthon Pharmaceuticals、LG Life Sciences、Novartis (Sandoz)、Celltrion、Biocon、Hospira、Merck Serono (Merck Group)、Biogen idec Inc.、Genentech (Roche Group) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：100mg/10ml、500mg/50ml ・用途別分析2016年-2026年：血液疾患、腫瘍疾患 ・レミケードバイオシミラーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・レミケードバイオシミラーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・レミケードバイオシミラーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・レミケードバイオシミラーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・レミケードバイオシミラーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Remicade Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Remicade Biosimilar size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Remicade Biosimilar market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Remicade Biosimilar market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
100mg/10ml
500mg/50ml
Market segment by Application can be divided into
Blood Disorders
Oncology Diseases
The key market players for global Remicade Biosimilar market are listed below:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Remicade Biosimilar Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Remicade Biosimilar Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 100mg/10ml
1.2.3 500mg/50ml
1.3 Market Analysis by Application
1.3.1 Overview: Global Remicade Biosimilar Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.4 Global Remicade Biosimilar Market Size & Forecast
1.4.1 Global Remicade Biosimilar Sales in Value (2016-2026))
1.4.2 Global Remicade Biosimilar Sales in Volume (2016-2026)
1.4.3 Global Remicade Biosimilar Price by Type (2016-2026) & (USD/MT)
1.5 Global Remicade Biosimilar Production Capacity Analysis
1.5.1 Global Remicade Biosimilar Total Production Capacity (2016-2026)
1.5.2 Global Remicade Biosimilar Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Remicade Biosimilar Market Drivers
1.6.2 Remicade Biosimilar Market Restraints
1.6.3 Remicade Biosimilar Trends Analysis
2 Manufacturers Profiles
2.1 Synthon Pharmaceuticals
2.1.1 Synthon Pharmaceuticals Details
2.1.2 Synthon Pharmaceuticals Major Business
2.1.3 Synthon Pharmaceuticals Remicade Biosimilar Product and Services
2.1.4 Synthon Pharmaceuticals Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 LG Life Sciences
2.2.1 LG Life Sciences Details
2.2.2 LG Life Sciences Major Business
2.2.3 LG Life Sciences Remicade Biosimilar Product and Services
2.2.4 LG Life Sciences Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Novartis (Sandoz)
2.3.1 Novartis (Sandoz) Details
2.3.2 Novartis (Sandoz) Major Business
2.3.3 Novartis (Sandoz) Remicade Biosimilar Product and Services
2.3.4 Novartis (Sandoz) Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Celltrion
2.4.1 Celltrion Details
2.4.2 Celltrion Major Business
2.4.3 Celltrion Remicade Biosimilar Product and Services
2.4.4 Celltrion Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Biocon
2.5.1 Biocon Details
2.5.2 Biocon Major Business
2.5.3 Biocon Remicade Biosimilar Product and Services
2.5.4 Biocon Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Hospira
2.6.1 Hospira Details
2.6.2 Hospira Major Business
2.6.3 Hospira Remicade Biosimilar Product and Services
2.6.4 Hospira Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Merck Serono (Merck Group)
2.7.1 Merck Serono (Merck Group) Details
2.7.2 Merck Serono (Merck Group) Major Business
2.7.3 Merck Serono (Merck Group) Remicade Biosimilar Product and Services
2.7.4 Merck Serono (Merck Group) Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Biogen idec Inc.
2.8.1 Biogen idec Inc. Details
2.8.2 Biogen idec Inc. Major Business
2.8.3 Biogen idec Inc. Remicade Biosimilar Product and Services
2.8.4 Biogen idec Inc. Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Genentech (Roche Group)
2.9.1 Genentech (Roche Group) Details
2.9.2 Genentech (Roche Group) Major Business
2.9.3 Genentech (Roche Group) Remicade Biosimilar Product and Services
2.9.4 Genentech (Roche Group) Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Remicade Biosimilar Sales by Manufacturer
3.1 Global Remicade Biosimilar Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Remicade Biosimilar Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Remicade Biosimilar
3.4 Market Concentration Rate
3.4.1 Top 3 Remicade Biosimilar Manufacturer Market Share
3.4.2 Top 6 Remicade Biosimilar Manufacturer Market Share
3.5 Global Remicade Biosimilar Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Remicade Biosimilar Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Remicade Biosimilar Market Size by Region
4.1.1 Global Remicade Biosimilar Sales in Volume by Region (2016-2026)
4.1.2 Global Remicade Biosimilar Revenue by Region (2016-2026)
4.2 North America Remicade Biosimilar Revenue (2016-2026)
4.3 Europe Remicade Biosimilar Revenue (2016-2026)
4.4 Asia-Pacific Remicade Biosimilar Revenue (2016-2026)
4.5 South America Remicade Biosimilar Revenue (2016-2026)
4.6 Middle East and Africa Remicade Biosimilar Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Remicade Biosimilar Sales in Volume by Type (2016-2026)
5.2 Global Remicade Biosimilar Revenue by Type (2016-2026)
5.3 Global Remicade Biosimilar Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Remicade Biosimilar Sales in Volume by Application (2016-2026)
6.2 Global Remicade Biosimilar Revenue by Application (2016-2026)
6.3 Global Remicade Biosimilar Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Remicade Biosimilar Sales by Type (2016-2026)
7.2 North America Remicade Biosimilar Sales by Application (2016-2026)
7.3 North America Remicade Biosimilar Market Size by Country
7.3.1 North America Remicade Biosimilar Sales in Volume by Country (2016-2026)
7.3.2 North America Remicade Biosimilar Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Remicade Biosimilar Sales by Type (2016-2026)
8.2 Europe Remicade Biosimilar Sales by Application (2016-2026)
8.3 Europe Remicade Biosimilar Market Size by Country
8.3.1 Europe Remicade Biosimilar Sales in Volume by Country (2016-2026)
8.3.2 Europe Remicade Biosimilar Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Remicade Biosimilar Sales by Type (2016-2026)
9.2 Asia-Pacific Remicade Biosimilar Sales by Application (2016-2026)
9.3 Asia-Pacific Remicade Biosimilar Market Size by Region
9.3.1 Asia-Pacific Remicade Biosimilar Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Remicade Biosimilar Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Remicade Biosimilar Sales by Type (2016-2026)
10.2 South America Remicade Biosimilar Sales by Application (2016-2026)
10.3 South America Remicade Biosimilar Market Size by Country
10.3.1 South America Remicade Biosimilar Sales in Volume by Country (2016-2026)
10.3.2 South America Remicade Biosimilar Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Remicade Biosimilar Sales by Type (2016-2026)
11.2 Middle East & Africa Remicade Biosimilar Sales by Application (2016-2026)
11.3 Middle East & Africa Remicade Biosimilar Market Size by Country
11.3.1 Middle East & Africa Remicade Biosimilar Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Remicade Biosimilar Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Remicade Biosimilar Typical Distributors
12.3 Remicade Biosimilar Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Remicade Biosimilar Revenue by Type, (USD Million), 2021-2026
Table 2. Global Remicade Biosimilar Revenue by Application, (USD Million), 2021-2026
Table 3. Synthon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Synthon Pharmaceuticals Major Business
Table 5. Synthon Pharmaceuticals Remicade Biosimilar Product and Services
Table 6. Synthon Pharmaceuticals Remicade Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 8. LG Life Sciences Major Business
Table 9. LG Life Sciences Remicade Biosimilar Product and Services
Table 10. LG Life Sciences Remicade Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis (Sandoz) Basic Information, Manufacturing Base and Competitors
Table 12. Novartis (Sandoz) Major Business
Table 13. Novartis (Sandoz) Remicade Biosimilar Product and Services
Table 14. Novartis (Sandoz) Remicade Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Celltrion Basic Information, Manufacturing Base and Competitors
Table 16. Celltrion Major Business
Table 17. Celltrion Remicade Biosimilar Product and Services
Table 18. Celltrion Remicade Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Biocon Basic Information, Manufacturing Base and Competitors
Table 20. Biocon Major Business
Table 21. Biocon Remicade Biosimilar Product and Services
Table 22. Biocon Remicade Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Hospira Basic Information, Manufacturing Base and Competitors
Table 24. Hospira Major Business
Table 25. Hospira Remicade Biosimilar Product and Services
Table 26. Hospira Remicade Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck Serono (Merck Group) Basic Information, Manufacturing Base and Competitors
Table 28. Merck Serono (Merck Group) Major Business
Table 29. Merck Serono (Merck Group) Remicade Biosimilar Product and Services
Table 30. Merck Serono (Merck Group) Remicade Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Biogen idec Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Biogen idec Inc. Major Business
Table 33. Biogen idec Inc. Remicade Biosimilar Product and Services
Table 34. Biogen idec Inc. Remicade Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Genentech (Roche Group) Basic Information, Manufacturing Base and Competitors
Table 36. Genentech (Roche Group) Major Business
Table 37. Genentech (Roche Group) Remicade Biosimilar Product and Services
Table 38. Genentech (Roche Group) Remicade Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Remicade Biosimilar Sales by Manufacturer (2019-2021e) & (K MT)
Table 40. Global Remicade Biosimilar Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Remicade Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Remicade Biosimilar Production Capacity by Company, (K MT): 2020 VS 2021
Table 43. Head Office and Remicade Biosimilar Production Site of Key Manufacturer
Table 44. Global Remicade Biosimilar Sales by Region (2016-2021e) & (K MT)
Table 45. Global Remicade Biosimilar Sales by Region (2021-2026) & (K MT)
Table 46. Global Remicade Biosimilar Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Remicade Biosimilar Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Remicade Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 49. Global Remicade Biosimilar Sales by Type (2021-2026) & (K MT)
Table 50. Global Remicade Biosimilar Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Remicade Biosimilar Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Remicade Biosimilar Price by Type (2016-2021e) & (USD/MT)
Table 53. Global Remicade Biosimilar Price by Type (2021-2026) & (USD/MT)
Table 54. Global Remicade Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 55. Global Remicade Biosimilar Sales by Application (2021-2026) & (K MT)
Table 56. Global Remicade Biosimilar Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Remicade Biosimilar Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Remicade Biosimilar Price by Application (2016-2021e) & (USD/MT)
Table 59. Global Remicade Biosimilar Price by Application (2021-2026) & (USD/MT)
Table 60. North America Remicade Biosimilar Sales by Country (2016-2021e) & (K MT)
Table 61. North America Remicade Biosimilar Sales by Country (2021-2026) & (K MT)
Table 62. North America Remicade Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Remicade Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Remicade Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 65. North America Remicade Biosimilar Sales by Type (2021-2026) & (K MT)
Table 66. North America Remicade Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 67. North America Remicade Biosimilar Sales by Application (2021-2026) & (K MT)
Table 68. Europe Remicade Biosimilar Sales by Country (2016-2021e) & (K MT)
Table 69. Europe Remicade Biosimilar Sales by Country (2021-2026) & (K MT)
Table 70. Europe Remicade Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Remicade Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Remicade Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 73. Europe Remicade Biosimilar Sales by Type (2021-2026) & (K MT)
Table 74. Europe Remicade Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 75. Europe Remicade Biosimilar Sales by Application (2021-2026) & (K MT)
Table 76. Asia-Pacific Remicade Biosimilar Sales by Region (2016-2021e) & (K MT)
Table 77. Asia-Pacific Remicade Biosimilar Sales by Region (2021-2026) & (K MT)
Table 78. Asia-Pacific Remicade Biosimilar Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Remicade Biosimilar Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Remicade Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 81. Asia-Pacific Remicade Biosimilar Sales by Type (2021-2026) & (K MT)
Table 82. Asia-Pacific Remicade Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 83. Asia-Pacific Remicade Biosimilar Sales by Application (2021-2026) & (K MT)
Table 84. South America Remicade Biosimilar Sales by Country (2016-2021e) & (K MT)
Table 85. South America Remicade Biosimilar Sales by Country (2021-2026) & (K MT)
Table 86. South America Remicade Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Remicade Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Remicade Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 89. South America Remicade Biosimilar Sales by Type (2021-2026) & (K MT)
Table 90. South America Remicade Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 91. South America Remicade Biosimilar Sales by Application (2021-2026) & (K MT)
Table 92. Middle East & Africa Remicade Biosimilar Sales by Country (2016-2021e) & (K MT)
Table 93. Middle East & Africa Remicade Biosimilar Sales by Country (2021-2026) & (K MT)
Table 94. Middle East & Africa Remicade Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Remicade Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Remicade Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 97. Middle East & Africa Remicade Biosimilar Sales by Type (2021-2026) & (K MT)
Table 98. Middle East & Africa Remicade Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 99. Middle East & Africa Remicade Biosimilar Sales by Application (2021-2026) & (K MT)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Remicade Biosimilar Typical Distributors
Table 103. Remicade Biosimilar Typical Customers
List of Figures
Figure 1. Remicade Biosimilar Picture
Figure 2. Global Remicade Biosimilar Sales Market Share by Type in 2020
Figure 3. 100mg/10ml
Figure 4. 500mg/50ml
Figure 5. Global Remicade Biosimilar Sales Market Share by Application in 2020
Figure 6. Blood Disorders
Figure 7. Oncology Diseases
Figure 8. Global Remicade Biosimilar Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 9. Global Remicade Biosimilar Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Remicade Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Remicade Biosimilar Sales (2016-2026) & (K MT)
Figure 30. Global Remicade Biosimilar Production Capacity (2016-2026) & (K MT)
Figure 31. Global Remicade Biosimilar Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Remicade Biosimilar Market Drivers
Figure 33. Remicade Biosimilar Market Restraints
Figure 34. Remicade Biosimilar Market Trends
Figure 35. Global Remicade Biosimilar Sales Market Share by Manufacturer in 2020
Figure 36. Global Remicade Biosimilar Revenue Market Share by Manufacturer in 2020
Figure 37. Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Remicade Biosimilar Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Remicade Biosimilar Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Remicade Biosimilar Sales Market Share by Region (2016-2026)
Figure 41. Global Remicade Biosimilar Revenue Market Share by Region (2016-2026)
Figure 42. North America Remicade Biosimilar Revenue (2016-2026) & (USD Million)
Figure 43. Europe Remicade Biosimilar Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Remicade Biosimilar Revenue (2016-2026) & (USD Million)
Figure 45. South America Remicade Biosimilar Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Remicade Biosimilar Revenue (2016-2026) & (USD Million)
Figure 47. Global Remicade Biosimilar Sales Market Share by Type (2016-2026)
Figure 48. Global Remicade Biosimilar Revenue Market Share by Type (2016-2026)
Figure 49. Global Remicade Biosimilar Price by Type (2016-2026) & (USD/MT)
Figure 50. Global Remicade Biosimilar Sales Market Share by Application (2016-2026)
Figure 51. Global Remicade Biosimilar Revenue Market Share by Application (2016-2026)
Figure 52. Global Remicade Biosimilar Price by Application (2016-2026) & (USD/MT)
Figure 53. North America Remicade Biosimilar Sales Market Share by Country (2016-2026)
Figure 54. North America Remicade Biosimilar Revenue Market Share by Country (2016-2026)
Figure 55. North America Remicade Biosimilar Sales Market Share by Type (2016-2026)
Figure 56. North America Remicade Biosimilar Sales Market Share by Application (2016-2026)
Figure 57. Europe Remicade Biosimilar Sales Market Share by Country (2016-2026)
Figure 58. Europe Remicade Biosimilar Revenue Market Share by Country (2016-2026)
Figure 59. Europe Remicade Biosimilar Sales Market Share by Type (2016-2026)
Figure 60. Europe Remicade Biosimilar Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Remicade Biosimilar Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Remicade Biosimilar Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Remicade Biosimilar Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Remicade Biosimilar Sales Market Share by Application (2016-2026)
Figure 65. South America Remicade Biosimilar Sales Market Share by Country (2016-2026)
Figure 66. South America Remicade Biosimilar Revenue Market Share by Country (2016-2026)
Figure 67. South America Remicade Biosimilar Sales Market Share by Type (2016-2026)
Figure 68. South America Remicade Biosimilar Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Remicade Biosimilar Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Remicade Biosimilar Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Remicade Biosimilar Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Remicade Biosimilar Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のインフリキシマブ＆バイオシミラー市場 2021：企業別、地域別、種類・用途別 The Infliximab and Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- 世界のバイオシミラー市場 2021：企業別、地域別、種類・用途別 The Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …
- 世界のバイオシミラー試験・開発サービス市場規模・現状・予測（2021年-2027年） The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified…
- 世界の神経バイオシミラー生物学的製剤市場 2021：企業別、地域別、種類・用途別 The Nerve Biosimilar Biological Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界のアダリムマブバイオシミラー市場 2021：企業別、地域別、種類・用途別 The Adalimumab Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…